Episode Description
Watch the webinar: Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions.
B cell–targeted therapies are becoming an important focus in autoimmune drug development. Early-phase decisions can have lasting implications for safety, development timelines, and future indication expansion.
In this discussion, our panel explores:
- Why B cell targeting is an attractive strategy in autoimmune right now.
- Clinical development considerations when considering healthy volunteers vs. patients.
- Early phase trial design.
- Safety management and risk mitigation.
- Opportunities across other indications.
Panelists:
- Prof. Sepehr Shakib, Consultant Medical Director, CMAX
- Dr. Carolyn Luscombe, Therapeutic Strategy Manager, Novotech
- Dr. Karen Scalzo-Inguanti, Director of Therapeutic Strategy, Novotech (Moderator)
Watch to gain practical insights to support informed early-phase development decisions.
Submit your questions and join the discussion.